hotspot -WSS

hotspot

author：explore 2025-09-28 00:51:58 - browse：8412

A pile of Zynex Medical batteries and electrode pads are seen at Michelle Bean's home — A pile of Zynex Medical batteries and electrode pads Kayana Szymczak for STAT

Sending patients heaps of medical supplies to score more money from insurers is common in the device industry. If insurers decline to cover the supplies, patients are stuck paying for materials they didn’t need.

STAT examined one of the companies perpetuating this practice, a pain management device company called Zynex Medical, and the frustration among both its patients and former employees. Here are five takeaways.

The ‘razor blade’ business model

Zynex sells nerve and muscle stimulation machines, known as TENS and EMS units, to treat pain and soothe muscles. But the company makes most of its money from monthly shipments of batteries and electrodes — almost 70% of its $184 million revenue in 2023 came from these supplies.

STAT+ Exclusive Story

Already have an account? Log in

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

Monthly

$39

Totals $468 per year

$39/month Get Started

Totals $468 per year

Starter

$30

for 3 months, then $39/month

$30 for 3 months Get Started

Then $39/month

Annual

$399

Save 15%

$399/year Get Started

Save 15%

11+ Users

Custom

Savings start at 25%!

Request A Quote Request A Quote

Savings start at 25%!

2-10 Users

$300

Annually per user

$300/year Get Started

$300 Annually per user

View All Plans

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies
Next article： Histogen: Failed biotech offers rare public look inside

WSS

Chemotherapy drug shortage eases slightly but still widespread

In $4.8 billion deal, Bristol Myers Squibb to buy cancer player Mirati

How one medical school became remarkably diverse

Cancer drug shortages should be causing more outrage

Dobbs anniversary: the lost opportunity of abortion as health care

Physician executives need more than on

explore

hotspot

The ‘razor blade’ business model

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

knowledge

Moonlake's readout produced a cash windfall. Risks remain

3 questions for the future of Biden's cancer moonshot

Supreme Court strikes down use of affirmative action

United colonoscopy coverage change 'may cost lives,' doctors say

Medical leaders decry Supreme Court decision on affirmative action

Novavax promises a turnaround & Lilly roils the obesity market

Psychedelics group wrestles with new pharma identity

As demand for Covid shots wanes, Moderna seeks its next success

In age of alternative facts, a scholarly course on calling out crap

Supreme Court strikes down use of affirmative action

entertainment

What to expect at HLTH 2023, the health care industry conference

Liquid biopsy for lung cancer is launched by Delfi

Continuity nursing helped my family in our darkest PICU moments

Medical leaders decry Supreme Court decision on affirmative action

Bill would stop addiction treatment from triggering child abuse inquiry

What does generative AI mean for health care? We asked experts

leisure time

entertainment

hotspot

entertainment